Terms: = Ovarian cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
63 results:
1. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.
Sun Y; Zhang K; Wang T; Zhao S; Gao C; Xue F; Wang Y
Sci Rep; 2024 Mar; 14(1):6134. PubMed ID: 38480789
[TBL] [Abstract] [Full Text] [Related]
3. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
Deng Y; Dong Y; Wu L; Zhang Q; Yang L
Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
[TBL] [Abstract] [Full Text] [Related]
4. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma.
Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
[TBL] [Abstract] [Full Text] [Related]
5. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
Dogra S; Elayapillai SP; Qu D; Pitts K; Filatenkov A; Houchen CW; Berry WL; Moxley K; Hannafon BN
Cancer Lett; 2023 Dec; 578():216437. PubMed ID: 37838282
[TBL] [Abstract] [Full Text] [Related]
6. Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer.
Price ZK; Lokman NA; Sugiyama M; Koya Y; Yoshihara M; Oehler MK; Kajiyama H; Ricciardelli C
Cell Mol Life Sci; 2023 Oct; 80(11):320. PubMed ID: 37815603
[TBL] [Abstract] [Full Text] [Related]
7. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
Li Q; Xiao X; Feng J; Yan R; Xi J
Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
[TBL] [Abstract] [Full Text] [Related]
8. The Role of emt-Related lncRNAs in ovarian cancer.
Lampropoulou DI; Papadimitriou M; Papadimitriou C; Filippou D; Kourlaba G; Aravantinos G; Gazouli M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373222
[TBL] [Abstract] [Full Text] [Related]
9. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
[TBL] [Abstract] [Full Text] [Related]
10. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract] [Full Text] [Related]
11. COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of ovarian Carcinoma.
Wang S; Liu Y; Li S; Chen Y; Liu Y; Yan J; Wu J; Li J; Wang L; Xiang R; Shi Y; Qin X; Yang S
Mol Cancer Res; 2023 Mar; 21(3):199-213. PubMed ID: 36445330
[TBL] [Abstract] [Full Text] [Related]
12. Systematic Pan-cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial ovarian cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract] [Full Text] [Related]
13. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.
Aghayousefi R; Hosseiniyan Khatibi SM; Zununi Vahed S; Bastami M; Pirmoradi S; Teshnehlab M
J Cancer Res Clin Oncol; 2023 Jan; 149(1):325-341. PubMed ID: 36378340
[TBL] [Abstract] [Full Text] [Related]
14. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
[TBL] [Abstract] [Full Text] [Related]
15. Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery.
Tang ZP; Ma Z; He Y; Liu RC; Jin BB; Wen DY; Wen R; Yin HH; Qiu CC; Gao RZ; Ma Y; Yang H
BMC Med Imaging; 2022 Aug; 22(1):147. PubMed ID: 35996097
[TBL] [Abstract] [Full Text] [Related]
16. miRNA-651-3p regulates emt in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract] [Full Text] [Related]
17. SIRT6 promotes mitochondrial fission and subsequent cellular invasion in ovarian cancer.
Bandopadhyay S; Prasad P; Ray U; Das Ghosh D; Roy SS
FEBS Open Bio; 2022 Sep; 12(9):1657-1676. PubMed ID: 35686673
[TBL] [Abstract] [Full Text] [Related]
18. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract] [Full Text] [Related]
19. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
20. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
Wang K; Liu S; Dou Z; Zhang S; Yang X
Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
[TBL] [Abstract] [Full Text] [Related]
[Next]
